Company intelligence / Profile preview

Richter BioLogics

Hamburg, Hamburg, Germanyrichterbiologics.eu ↗

Ownership: Private
Development stage: Commercial

Overview

Richter BioLogics is an established German CDMO with over 35 years of experience in microbial-derived biopharmaceuticals. It offers process development, clinical trial material supply, commercial production, QC testing, and QP release for plasmid DNA, antibodies (including nanobodies), proteins, and vaccines. The company's facilities are cGMP-compliant and approved by major regulatory agencies including EMA and FDA. It recently expanded with a new large-scale GMP facility to meet growing demand.

Modalities: Plasmid DNAMonoclonal antibody fragmentRecombinant proteinVaccine
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

teriparatide

Commercial

Indications: Osteoporosis

Beyond the preview

Go deeper on Richter BioLogics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Richter BioLogics.

Explore the full profile